|
Volumn 276, Issue 7392, 2006, Pages 323-326
|
Colorectal cancer: An overview
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
ANTIINFECTIVE AGENT;
ATROPINE;
BEVACIZUMAB;
BUDESONIDE;
CAPECITABINE;
CETUXIMAB;
CIPROFLOXACIN;
CODEINE PHOSPHATE;
DEXAMETHASONE;
DOMPERIDONE;
FLUOROURACIL;
FOLINATE CALCIUM;
IRINOTECAN;
LOPERAMIDE;
METOCLOPRAMIDE;
MONOCLONAL ANTIBODY;
OCTREOTIDE;
OXALIPLATIN;
SEROTONIN AGONIST;
SODIUM CHLORIDE;
SUCRALFATE;
UFT;
ACNE;
ADENOMATOUS POLYP;
ADULT;
AGE;
AGED;
ALOPECIA;
ARTICLE;
ASTHENIA;
BARIUM ENEMA;
BLEEDING;
BONE MARROW SUPPRESSION;
CANCER ADJUVANT THERAPY;
CANCER INCIDENCE;
CANCER RECURRENCE;
CANCER RISK;
CANCER SCREENING;
CANCER STAGING;
CANCER SURVIVAL;
CAUSE OF DEATH;
CEREBELLUM DISEASE;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
COLONOSCOPY;
COLORECTAL CANCER;
COOLING;
DIARRHEA;
DIET RESTRICTION;
DIETARY INTAKE;
DIGESTIVE SYSTEM PERFORATION;
DOSE RESPONSE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG HYPERSENSITIVITY;
DRUG MEGADOSE;
EARLY DIAGNOSIS;
ENVIRONMENTAL FACTOR;
FAMILY HISTORY;
FEMALE;
HAND FOOT SYNDROME;
HEALTH PROGRAM;
HEALTH PROMOTION;
HEREDITY;
HUMAN;
HUMAN TISSUE;
HYPERTENSION;
INJECTION SITE REACTION;
INTESTINE CANCER;
LIVER FUNCTION TEST;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MOUTHWASH;
MUCOSA INFLAMMATION;
NAUSEA AND VOMITING;
NEUROLOGIC DISEASE;
NEUROTOXICITY;
NURSING;
NUTRITIONAL SUPPORT;
OBESITY;
OVERALL SURVIVAL;
PATIENT REFERRAL;
PHARMACIST;
PHYSICAL ACTIVITY;
PRACTICE GUIDELINE;
PREOPERATIVE CARE;
PREVALENCE;
PRIMARY PREVENTION;
RISK ASSESSMENT;
RISK FACTOR;
RISK REDUCTION;
SIDE EFFECT;
SMOKING;
SMOKING CESSATION;
STOMA;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
SURVIVAL TIME;
SYMPTOMATOLOGY;
THORAX PAIN;
THROMBOEMBOLISM;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TUMOR BIOPSY;
TUMOR VOLUME;
WEIGHT REDUCTION;
WOUND HEALING IMPAIRMENT;
|
EID: 33645467905
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (7)
|